Xconomy’s Digital Events →
June 11, 2020 · New York
June 25, 2020 · San Francisco
October 1, 2020 · Seattle
Aastrom Biosciences is an Ann Arbor-based startup working on mutlicell treatments for critical limb ischemia and dilated cardiomyopathy.
Sponsored · Whitepaper
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.